Nifty

:

18338.55

Sensex

:

61305.95

176.80 (0.97%)
568.90 (0.94%)

Login

Nifty
Sensex

:
:

18338.55
61305.95

176.80 (0.97%)
568.90 (0.94%)

Albert David Ltd.

Pharmaceuticals & Drugs

Rating :

53/99

BSE: 524075 | NSE: ALBERTDAVD

Watchlist

NSE BSE

617.55

14-Oct-2021

Open
High
Low
Previous Close

616.85
624.95
606.30
615.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

86902
535.35
673.80
374.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

351.79
10.46
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

318.04
0.97%
1.38

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.69
-3.48
-7.94

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-2.16
1.25
-7.99

PAT CAGR (%)

10 Years
5 Years
3 Years

11.24
6.77
-5.98

P:E (Median)

8 Years
5 Years
3 Years

11.31
12.55
12.04

P:BV (Average)

8 Years
5 Years
3 Years

1.12
1.12
1.12

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.61
7.76
6.97

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 81.10 53.73 50.94% 56.74 60.00 -5.43% 65.29 79.56 -17.94% 71.69 89.61 -20.00%
Expenses 70.76 58.11 21.77% 50.14 62.30 -19.52% 59.58 72.83 -18.19% 60.46 77.07 -21.55%
EBITDA 10.34 -4.38 - 6.59 -2.29 - 5.71 6.73 -15.16% 11.22 12.54 -10.53%
EBIDTM 12.75% -8.16% 11.62% -3.82% 8.75% 8.46% 15.66% 13.99%
Other Income 5.05 4.78 5.65% 4.48 0.84 433.33% 4.89 2.94 66.33% 3.03 1.46 107.53%
Interest 0.15 0.17 -11.76% 0.17 0.19 -10.53% 0.17 0.19 -10.53% 0.14 0.20 -30.00%
Depreciation 2.00 2.03 -1.48% 2.05 2.04 0.49% 2.08 1.89 10.05% 2.07 1.88 10.11%
PBT 13.25 -1.80 - 8.85 -3.68 - 8.35 7.59 10.01% 12.04 11.91 1.09%
Tax 2.80 -0.74 - 1.56 -0.38 - 2.23 2.34 -4.70% 2.25 3.99 -43.61%
PAT 10.44 -1.06 - 7.29 -3.30 - 6.12 5.25 16.57% 9.79 7.92 23.61%
PATM 12.88% -1.97% 12.85% -5.50% 9.37% 6.60% 13.66% 8.84%
EPS 18.32 -1.86 - 12.79 -5.79 - 10.74 9.21 16.61% 17.18 13.90 23.60%

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 274.82 247.45 320.80 317.20 290.34 295.32 322.60 321.78 290.64 265.07 231.12 Net Sales Growth -2.86% -22.86% 1.13% 9.25% -1.69% -8.46% 0.25% 10.71% 9.65% 14.69% Cost Of Goods Sold 96.45 69.66 74.30 75.08 59.66 55.87 59.90 64.25 64.96 53.31 42.43 Gross Profit 178.37 177.79 246.50 242.12 230.68 239.45 262.71 257.53 225.67 211.75 188.68 GP Margin 64.91% 71.85% 76.84% 76.33% 79.45% 81.08% 81.44% 80.03% 77.65% 79.88% 81.64% Total Expenditure 240.94 228.17 290.29 287.96 274.53 277.20 291.31 284.90 257.82 239.17 207.14 Power & Fuel Cost - 8.52 13.83 12.77 12.57 12.04 16.30 16.04 14.21 18.60 16.78 % Of Sales - 3.44% 4.31% 4.03% 4.33% 4.08% 5.05% 4.98% 4.89% 7.02% 7.26% Employee Cost - 82.70 90.34 89.89 86.30 83.18 81.60 75.24 64.50 56.18 54.58 % Of Sales - 33.42% 28.16% 28.34% 29.72% 28.17% 25.29% 23.38% 22.19% 21.19% 23.62% Manufacturing Exp. - 24.71 40.29 42.43 43.04 41.98 49.99 60.01 55.11 54.62 47.47 % Of Sales - 9.99% 12.56% 13.38% 14.82% 14.22% 15.50% 18.65% 18.96% 20.61% 20.54% General & Admin Exp. - 12.92 23.50 22.07 26.09 27.49 30.53 27.46 24.17 24.04 18.69 % Of Sales - 5.22% 7.33% 6.96% 8.99% 9.31% 9.46% 8.53% 8.32% 9.07% 8.09% Selling & Distn. Exp. - 22.64 34.55 36.48 37.39 42.10 48.57 38.28 32.33 29.95 26.11 % Of Sales - 9.15% 10.77% 11.50% 12.88% 14.26% 15.06% 11.90% 11.12% 11.30% 11.30% Miscellaneous Exp. - 7.01 13.48 9.24 9.48 14.55 4.42 3.62 2.54 2.48 26.11 % Of Sales - 2.83% 4.20% 2.91% 3.27% 4.93% 1.37% 1.12% 0.87% 0.94% 0.46% EBITDA 33.86 19.28 30.51 29.24 15.81 18.12 31.29 36.88 32.82 25.90 23.98 EBITDA Margin 12.32% 7.79% 9.51% 9.22% 5.45% 6.14% 9.70% 11.46% 11.29% 9.77% 10.38% Other Income 17.45 17.18 7.11 21.49 9.50 15.84 1.97 1.80 0.60 1.75 0.96 Interest 0.63 0.78 0.98 0.86 1.01 0.90 2.05 2.99 3.90 3.53 3.92 Depreciation 8.20 8.23 7.67 7.02 8.37 7.52 9.00 15.41 11.06 10.73 9.78 PBT 42.49 27.44 28.95 42.86 15.93 25.54 22.21 20.27 18.46 13.39 11.24 Tax 8.84 5.30 9.79 16.22 6.09 9.59 15.02 6.57 5.89 4.83 3.61 Tax Rate 20.80% 19.31% 33.82% 37.84% 38.23% 37.55% 23.83% 32.41% 31.91% 36.07% 32.12% PAT 33.64 22.14 19.17 26.64 9.84 15.96 48.00 13.70 12.57 8.56 7.63 PAT before Minority Interest 33.64 22.14 19.17 26.64 9.84 15.96 48.00 13.70 12.57 8.56 7.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.24% 8.95% 5.98% 8.40% 3.39% 5.40% 14.88% 4.26% 4.32% 3.23% 3.30% PAT Growth 281.84% 15.49% -28.04% 170.73% -38.35% -66.75% 250.36% 8.99% 46.85% 12.19% EPS 59.02 38.84 33.63 46.74 17.26 28.00 84.21 24.04 22.05 15.02 13.39

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 244.38 222.80 210.45 185.95 183.01 136.83 92.82 90.34 81.11 75.55 Share Capital 5.71 5.71 5.71 5.71 5.71 5.71 5.71 5.71 5.71 5.71 Total Reserves 238.67 217.09 204.74 180.24 177.31 131.12 87.11 84.63 75.40 69.85 Non-Current Liabilities 25.56 26.79 19.91 14.73 9.29 7.97 13.96 59.03 42.15 40.58 Secured Loans 0.39 1.44 0.00 0.00 0.00 0.00 6.00 11.96 8.02 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 19.73 20.80 14.19 13.87 8.87 7.21 6.51 39.93 26.29 33.61 Current Liabilities 135.29 148.56 145.45 160.20 158.53 119.85 124.55 115.27 86.34 86.70 Trade Payables 31.95 38.22 29.69 31.75 27.34 26.55 30.56 30.35 28.39 31.11 Other Current Liabilities 27.01 25.03 19.10 14.89 18.55 18.15 18.63 16.32 14.49 12.37 Short Term Borrowings 0.43 0.00 0.44 27.64 30.03 20.23 22.10 27.89 29.77 33.68 Short Term Provisions 75.90 85.31 96.22 85.92 82.61 54.92 53.25 40.71 13.69 9.53 Total Liabilities 405.23 398.15 375.81 360.88 350.83 264.65 231.33 264.64 209.60 202.83 Net Block 83.96 91.00 77.09 82.84 86.76 44.44 49.47 67.45 71.92 69.43 Gross Block 211.62 211.59 191.83 191.89 221.26 171.51 167.91 162.41 156.69 143.81 Accumulated Depreciation 127.66 120.59 114.74 109.05 134.50 127.07 118.43 94.96 84.77 74.38 Non Current Assets 126.87 129.67 113.19 117.75 116.41 68.62 73.66 123.31 95.04 103.72 Capital Work in Progress 0.75 1.52 5.06 5.25 8.67 5.01 5.04 2.60 1.34 6.03 Non Current Investment 23.86 24.17 21.43 18.90 16.75 16.50 16.50 16.50 0.00 0.00 Long Term Loans & Adv. 13.14 12.88 9.46 9.35 2.89 2.58 2.51 36.59 21.73 28.19 Other Non Current Assets 5.15 0.10 0.15 1.41 1.35 0.09 0.14 0.17 0.04 0.07 Current Assets 278.36 268.48 262.62 243.13 234.42 196.03 157.67 141.33 114.55 99.11 Current Investments 113.82 97.61 91.55 48.98 42.16 31.04 0.00 0.00 0.00 0.00 Inventories 35.75 42.72 44.06 43.21 50.66 48.54 52.14 43.12 42.56 40.25 Sundry Debtors 19.49 30.13 21.77 27.32 33.07 35.46 41.08 42.59 36.97 29.76 Cash & Bank 35.37 6.75 7.13 25.66 14.79 23.17 9.98 9.26 14.53 11.54 Other Current Assets 73.94 1.99 0.38 1.87 93.74 57.81 54.48 46.36 20.49 17.56 Short Term Loans & Adv. 71.78 89.28 97.74 96.10 93.09 57.27 53.68 45.68 19.87 6.08 Net Current Assets 143.07 119.92 117.17 82.93 75.89 76.18 33.12 26.06 28.22 12.41 Total Assets 405.23 398.15 375.81 360.88 350.83 264.65 231.33 264.64 209.59 202.83

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 36.61 30.25 31.87 30.01 19.87 68.04 27.82 20.78 20.24 10.86 PBT 27.44 28.95 42.86 15.93 25.54 22.21 20.27 18.46 13.39 11.24 Adjustment -7.45 7.23 -12.88 2.80 2.23 63.00 17.84 14.52 13.73 12.62 Changes in Working Capital 18.92 9.27 8.22 18.52 3.16 9.75 -3.03 -5.45 -2.45 -7.06 Cash after chg. in Working capital 38.91 45.45 38.21 37.25 30.94 94.96 35.08 27.54 24.66 16.80 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.30 -15.20 -6.34 -7.23 -11.07 -26.93 -7.27 -6.76 -4.42 -5.93 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -36.68 -20.00 -19.07 -11.03 -36.60 -38.34 -9.04 -23.99 -9.13 -12.40 Net Fixed Assets 0.74 -16.22 0.25 32.79 -53.41 -3.57 -7.94 -6.98 -8.19 -7.85 Net Investments -15.90 -8.80 -45.10 -8.97 -11.37 -31.04 0.00 -16.50 0.00 0.00 Others -21.52 5.02 25.78 -34.85 28.18 -3.73 -1.10 -0.51 -0.94 -4.55 Cash from Financing Activity -1.71 -10.33 -17.09 -4.56 6.69 -17.93 -18.07 -2.06 -8.12 -10.57 Net Cash Inflow / Outflow -1.78 -0.08 -4.29 14.42 -10.04 11.77 0.71 -5.28 3.00 -12.10 Opening Cash & Equivalents 6.42 6.41 10.71 -3.92 5.87 9.77 9.06 14.53 11.54 23.64 Closing Cash & Equivalent 4.64 6.42 6.41 10.71 -3.92 21.72 9.77 9.26 14.53 11.54

Financial Ratios

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 428.20 390.38 368.74 325.81 320.67 239.75 162.64 158.29 142.11 132.38 ROA 5.51% 4.95% 7.23% 2.77% 5.18% 19.35% 5.52% 5.30% 4.15% 3.82% ROE 9.48% 8.85% 13.44% 5.33% 9.98% 41.80% 14.96% 14.67% 10.93% 10.42% ROCE 11.99% 13.74% 20.60% 7.94% 14.29% 46.48% 18.22% 17.79% 14.45% 13.00% Fixed Asset Turnover 1.23 1.67 1.74 1.50 1.56 1.97 2.02 2.07 2.02 1.86 Receivable days 34.76 28.06 26.88 35.54 40.81 41.85 45.67 43.92 40.16 34.04 Inventory Days 54.98 46.93 47.78 55.23 59.07 55.04 52.00 47.30 49.83 51.88 Payable days 60.01 46.81 42.46 43.86 38.04 35.29 37.38 41.75 44.58 46.01 Cash Conversion Cycle 29.73 28.18 32.19 46.91 61.84 61.60 60.29 49.47 45.41 39.92 Total Debt/Equity 0.01 0.01 0.00 0.15 0.16 0.15 0.32 0.47 0.47 0.53 Interest Cover 36.00 30.41 50.78 16.73 29.37 31.69 7.77 5.73 4.79 3.87

Top Investors:

general insurance corporation of india

Annual Reports:

News Update:

Albert David, Corona Remedies enter into strategic co-marketing agreement
5th Oct 2021, 12:35 PM

The company has entered into a strategic Co-Marketing agreement to help take the ‘Placenta Products (Placentrex)’, with another brand name, to a larger and wider group of end beneficiaries
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback